Keros Therapeutics (KROS) saw its shares surge in the last session with trading volume being higher than average. The latest ...

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and ...

Takeda. "The Top Employer Institute recognition reflects our commitment to a diverse and inclusive culture by investing in our people's growth through creating an engaging lifelong learning ...

Tempus AI claims to have a one-stop-shop, with a flywheel platform that becomes better with each new client. See why I rate ...

Be Biopharma, Inc. ("Be Bio" or "the Company"), a leader in B Cell Medicines (BCMs), today announced the closing of its $92M Series C financing. The round includes participation from new investor ...

Fortune Brands Innovations has leased the majority of the former Horizon Therapeutics headquarters as relocates employees from other cities to the northern suburb.

Several companies including Roche, Takeda, J&J, AbbVie ... generated total revenues of $829.3 million in 2023, up 26% year over year. Putting together a successful investment portfolio takes ...

The company has a license and collaboration agreement with Takeda to commercialize rusfertide ... revenue is $947.4 million with a 41.4% net profit margin. Year-over-year quarterly sales growth most ...